Related Experiment Videos
Improved immunoturbidimetric assay for cystatin C.
A V Lewis1, T J James, J B McGuire
1Department of Clinical Biochemistry, Oxford Radcliffe Hospital, Headington, UK.
Annals of Clinical Biochemistry
|March 28, 2001
Summary
Optimizing the cystatin C assay reduced imprecision, enhancing its reliability for clinical use. Modifications improved interference tolerance, making the assay more robust for routine diagnostics.
Area of Science:
- Clinical Chemistry
- Biochemical Assays
- Immunoturbidimetry
Background:
- Cystatin C is a biomarker for kidney function.
- Assay imprecision can limit diagnostic utility.
- Optimization is needed for reliable cystatin C measurement.
Purpose of the Study:
- To optimize an immunoturbidimetric assay for cystatin C.
- To reduce assay imprecision and improve reliability.
- To assess the impact of modifications on assay performance.
Main Methods:
- Investigated optimal pH, polyethylene glycol concentration, and specimen volume.
- Increased specimen volume to 25 microL.
- Extended pre-incubation period to 240 seconds.
Main Results:
- Achieved between-batch imprecision (CV) from 3-9% at 0.72 mg/L to 1.3% at 5.29 mg/L.
- The modified assay showed improved tolerance to lipaemia and haemolysis.
- Bilirubinaemia did not interfere with the assay.
Conclusions:
- The optimized cystatin C assay demonstrates reduced imprecision.
- Extended pre-incubation enhances tolerance to common interferences.
- The modified assay is suitable for routine clinical settings.